跳至主要内容
临床试验/NCT06582992
NCT06582992尚未招募不适用

EPIGENETIC-SENSITIVE BIOMARKERS OF INFLAMMAGING FROM HEALTHY TO HEART FAILURE DISEASE

University of Campania "Luigi Vanvitelli"1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年11月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
试验地点
1
主要终点
Number of differentially methylated positions and regions as assessed by RRBS

研究概览

简要总结

The goal of this observational study is to profile changes in DNA methylation of circulating CD4+ T and CD8+ T cells from healthy young to aged with diagnosis of HFpEF, a particular phenotype of HF which is highly prevalent in aging.

The main question it aims to answer is:

-Do DNA methylation biomarkers help us to understand the role of inflammation in HFpEF during aging?

Our goal is to provide a simple large-scale panel of epigenetic-sensitive biomarkers useful in aged patients with HF in the early natural history of the disease (HFpEF).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects aged between 18 and 40 years
  • Aged subjects (≥65) without signs and symptoms of heart failure
  • Aged subjects (≥65) with diagnosis of heart failure with preserved ejection fraction (EF major than 50%)

排除标准

  • Heart failure with reduced ejection fraction (EF minor than 40%)
  • Heart failure with mildly reduced EF (HFmrEF) (EF 41-49%)
  • History or diagnosis of cancer and inflammatory diseases

结局指标

主要结局

Number of differentially methylated positions and regions as assessed by RRBS

时间窗: 6 months

We will identify a panel of positions and regions of the genome which are differentially methylated using as measure diff.meth more than or minor than 2 and p minor than 0.05

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giuditta Benincasa

Principal Investigator

University of Campania "Luigi Vanvitelli"

研究点 (1)

Loading locations...

相似试验